Page 19 - Syndipharma
P. 19

Arya Pharmaceutical Co.


            IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY





                 Founded:                    November 1958,

                 HQ Office & Plant Location:  Daroupakhsh Ave., Makhsoos Karaj (LashKari) Rd., Tehran, 1397133111, Iran

                 Major Shareholder:          Individuals from privates sector.

                 Capital:                    IRR 140,400,000,000


                 Employees:                  Almost 250 employees including more than 40 professional specialists (e.g. phar-
                                             macist doctors, engineers, expert chemists, MS experts)

                 Company Profile:
                 In November 1958, Ministry of Health issued the permit of Gerami Pharmaceutical Laboratory on Dr. Sayyed Moham-
                 mad Gerami’s request. In the early 80s, the company was further expanded by a group of prominent figures under
                 the name of “Generic Pharma” which later on, changed to “Arya Pharmaceutical Company.” Aria has been one of the
                 nationwide pioneers in manufacturing over 71 types of different products in the form of tablets and capsules, and
                 ever since, has constantly been developing its process of manufacturing quality products through financial invest-
                 ment and expansion of the facilities. The firm is conducting extensive in-house research; it is over 5 years that our
                 QAD has been established. Our QCD is accredited by Iranian FDCL and MOH. The company’s Research and Devel-
                 opment Department is active and deeply involved in working on new molecules. Thanks to modern equipment and
                 qualified personnel, Arya Pharmaceutical has been a well-known company producing high quality products in Iran’s
                 pharmaceuticals market since 1989.


                 Production Lines:
                 Arya pharmaceutical Company is well-experienced in the production of sustained release and delayed release formu-
                 lations. Its production line consists of three separate lines of tablet, capsule, and antibiotics. The production capacity
                 is over 1.2 billion tablets and capsules per year.


                 PremierPartners:
                 Cipla Pharmaceuticals

                 Certificates:
                 We are working in accordance with PIC/S guidelines and have already received two GMP certificates.



                 Target Countries for Exports:
                 The Middle East, the CIS countries, and also iraq.



                 Contact details:
                 Address: Daroupakhsh Ave., Makhsoos Karaj (Lashkari) Rd., Tehran, 1397133111, Iran
                 Tel: +98 21 44981081-3
                 Fax: +98 21 44989243
                 Website: www.aryapharm.com
                 Email Address: Info@ariapharm.com



               Product List



          18
   14   15   16   17   18   19   20   21   22   23   24